Browsing by Author "Visa Turmo, Laura"

Sort by: Order: Results:

  • Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
    Visa Turmo, Laura; Carmona-Bayonas, Alberto; AGAMENON Study Group (Elsevier, 2018)
    OBJECTIVE: Advanced gastric cancer (AGC) is a common neoplasm in older adults. Nevertheless, there are few specific management data in the literature. The aim of this study was to assess non-inferiority of survival and ...
  • Feasibility, tolerability, and effects of exercise-based prehabilitation after neoadjuvant therapy in esophagogastric cancer patients undergoing surgery: an interventional pilot study
    Argudo Aguirre, Nuria; Rodó-Pin, Anna; Martinez-Llorens, Juana María; Marco Navarro, Ester; Visa Turmo, Laura; Messaggi-Sartor, Monique, 1984-; Balañá Corberó, Ana, 1981-; Ramón Moros, José Manuel; Rodríguez Chiaradia, Diego Agustín; Grande Posa, Luís; Pera Roman, Manuel Ramón (Oxford University Press, 2021)
    Patients requiring surgery for locally advanced esophagogastric cancer often require neoadjuvant therapy (NAT), which may have a detrimental impact on cardiorespiratory reserve. The aims of this study were to investigate ...
  • Geriatric oncology in Spain: survey results and analysis of the current situation
    Gironés i Sarrió, Regina; Visa Turmo, Laura; Pi-Figueras Valls, María; Spanish Working Group on Geriatric Oncology of the Spanish Society of Medical Oncology (SEOM) (SpringerOpen, 2018)
    INTRODUCTION: Geriatric oncology (GO) is a discipline that focuses on the management of elderly patients with cancer. The Spanish Society of Medical Oncology (SEOM) created a Working group dedicated to geriatric oncology ...
  • HER-family ligands promote acquired resistance to trastuzumab in gastric cancer
    Sampera Borràs, Aïda, 1990-; Sánchez-Martín, Francisco Javier; Arpí Llucià, Oriol; Visa Turmo, Laura; Iglesias Coma, Mar; Menéndez, Silvia; Gaye, Élisabeth; Dalmases Massegú, Alba, 1982-; Clavé Safont, Sergi; Gelabert-Baldrich, Mariona; Tuxen Poulsen, Thomas; Kragh, Michael; Bellosillo Paricio, Beatriz; Albanell Mestres, Joan; Rovira Guerín, Ana; Rovira Guerín, Ana; Montagut Viladot, Clara (American Association for Cancer Research (AACR), 2019)
    Despite the clinical benefit of trastuzumab, eventually all HER2-amplified gastric cancer tumors develop drug resistance. We aimed to identify molecular mechanisms of acquired resistance to trastuzumab in gastric cancer ...
  • Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker
    Martínez Bosch, Neus; Barranco Priego, Luis Eugenio; Orozco, Carlos Alberto; Moreno, Mireia; Visa Turmo, Laura; Iglesias Coma, Mar; Oldfield, Lucy; Neoptolemos, John P.; Greenhalf, William; Earl, Julie; Carrato, Alfredo; Costello, Eithne; Navarro Medrano, Pilar (Impact Journal, 2018)
    Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the deadliest diseases overall. New biomarkers are urgently needed to allow early diagnosis, one of the only factors that ...
  • Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial
    Radosevic, Aleksandar, 1974-; Quesada Diez, Rita; Serlavos, Clara; Sánchez, Juan; Zugazaga Cortázar, Ander; Sierra, Ana; Coll Estrada, Susanna; Busto Barrera, Marcos; Aguilar, Guadalupe; Flores Pereyra, Daniel; Arce, Javier; Maiques Llácer, José María; Garcia-Retortillo, Montserrat; Carrión Rodríguez, José Antonio; Visa Turmo, Laura; Villamonte, Maria; Pueyo Périz, Eva M.; Sánchez Velázquez, Patricia, 1985-; Grande Posa, Luís; Burdío Pinilla, Fernando (Nature Research, 2022)
    Microwave (MWA) and radiofrequency ablation (RFA) are main ablative techniques for hepatocellular carcinoma (HCC) and colorectal liver metastasis (MT). This randomized phase 2 clinical trial compares the effectiveness of ...
  • Prognostic factors in oncological patients with solid tumours requiring intensive care unit admission
    Bosch-Compte, Raquel; Visa Turmo, Laura; Rios, Alejandro; Duran Jordà, Xavier, 1974-; Fernández-Real, Maria; Gomariz-Vilaldach, Gemma; Masclans Enviz, Joan Ramon (Spandidos Publications, Ltd., 2023)
    The aim of the present study was to identify factors predicting in-hospital mortality in patients with cancer admitted to a medical Intensive Care Unit (ICU), and to evaluate their functional status and survival during ...
  • Radiofrequency-assisted transection of the pancreas vs stapler in distal pancreatectomy: a propensity score matched cohort analysis
    Pueyo Périz, Eva M.; Téllez-Marquès, C.; Radosevic, Aleksandar, 1974-; Morató Redondo, Olga; Visa Turmo, Laura; Ilzarbe Sánchez, Lucas; Berjano, Enrique J.; de Vicente, E.; Poves Prim, José Ignacio; Ielpo, Benedetto; Grande Posa, Luís; Burdío Pinilla, Fernando; Sánchez Velázquez, Patricia, 1985- (Nature Research, 2022)
    To demonstrate the efficacy of radiofrequency for pancreatic stump closure in reducing the incidence of postoperative pancreatic fistula (POPF) in distal pancreatectomy (DP) compared with mechanical transection methods. ...
  • Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry
    Cotes Sanchís, Almudena; Visa Turmo, Laura; Carmona-Bayonas, Alberto (Public Library of Science (PLoS), 2020)
    Background: Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice. Materials ...
  • Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
    Gallego Plazas, J.; Visa Turmo, Laura; Carmona-Bayonas, Alberto (Elsevier, 2022)
    Background: recommendations for research articles include the use of the term sex when reporting biological factors and gender for identities or psychosocial or cultural factors. There is an increasing awareness of ...
  • Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
    Martínez Bosch, Neus; Cristóbal, Helena; Iglesias Coma, Mar; Gironella, Meritxell; Barranco Priego, Luis Eugenio; Visa Turmo, Laura; Calafato, Domenico; Jiménez-Parrado, Silvia; Earl, Julie; Carrato, Alfredo; Manero Rupérez, Noemí; Moreno, Mireia; Morales, Albert; Guerra, Carmen; Navarro Medrano, Pilar; García de Frutos, Pablo (Elsevier, 2022)
    Background: Early diagnosis is crucial for patients with pancreatic ductal adenocarcinoma (PDAC). The AXL receptor tyrosine kinase is proteolytically processed releasing a soluble form (sAXL) into the blood stream. Here ...
  • The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer.
    Sanchez Martin, Francisco Javier; Bellosillo Paricio, Beatriz; Gelabert-Baldrich, Mariona; Dalmases Massegú, Alba, 1982-; Cañadas Castillo, Israel, 1984-; Vidal Barrull, Joana; Martinez, Alejandro; Argiles, Guillem; Visa Turmo, Laura; Arpí Llucià, Oriol; Iglesias García, Mar; Rovira Guerín, Ana; Albanell Mestres, Joan; Tabernero Cartula, Josep; Montagut Viladot, Clara (American Association for Cancer Research, 2016)
    PURPOSE: Approved anti-EGFR antibodies cetuximab and panitumumab provide significant clinical benefit in patients with metastatic colorectal cancer (MCRC). However, patients ultimately develop disease progression, often ...
  • The Galectin family as molecular targets: hopes for defeating pancreatic cancer
    Manero Rupérez, Noemí; Martínez Bosch, Neus; Barranco Priego, Luis Eugenio; Visa Turmo, Laura; Navarro Medrano, Pilar (MDPI, 2020)
    Galectins are a family of proteins that bind β-galactose residues through a highly conserved carbohydrate recognition domain. They regulate several important biological functions, including cell proliferation, adhesion, ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking